Brenus Pharma is awarded by pharmaceutical or academic top players in oncology

April 28, 2021

Brenus Pharma has passed through MATWIN year multi-step process of examination by key stakeholders and experts from academic or pharmaceutical worlds. Unique in Europe, MATWIN (Maturation & Accelerating Translation With INdustry) is an open-innovation platform that aims at developing translational research in oncology and accelerating innovation transfer from bench to the bedside.

Have reviewed our dossier : Amgen France, AstraZeneca, Bristol Myers Squibb, Boehringer Ingelheim, Exact Sciences, Gilead Sciences, GSK, NanoString Technologies, Inc., Novartis France, Pfizer, Pierre Fabre Group, Roche, Sanofi-Aventis France S.A.